Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

NCT04348747 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Malignant Neoplasm in the Brain
Metastatic Triple-Negative Breast Carcinoma
Prognostic Stage IV Breast Cancer AJCC v8

Interventions

BIOLOGICAL: Anti-HER2/HER3 Dendritic Cell Vaccine
BIOLOGICAL: Pembrolizumab

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]